| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 8e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |